Dyer, IN (PRWEB) February 13, 2009
OralDNA Labs, Inc. (http://www.OralDNA.com), a Specialty Diagnostics Company focused on bringing advanced laboratory testing to the dental community, today announced it has reached an agreement to provide diagnostic testing for the Center for Implants, Sedation and Cosmetic Dentistry. OralDNA will provide diagnostic laboratory testing to the Center and Dyer Family Dentistry to enable state-of-the-art diagnosis of periodontal disease. The tests will enable better identification and, consequently, earlier treatment of the bacterial infection that causes periodontal disease. Periodontal disease is estimated to effect three quarters of the adult population in the United States.
"We are pleased to be at the forefront of bringing diagnostic testing to dentistry in order to treat periodontal disease with the same importance as we do inflammatory infections in other areas of the body," said Dr. Irfan (Ivan) Atcha, president and CEO of the Center for Implants and Dyer Family Dentistry. "As we continue to understand and identify the systemic link between oral health and full body health, we feel that providing our patients and clinicians a tool for identifying the cause and severity of their periodontal infection is critical. This technology combined with comprehensive clinical care will enhance our ability to have the most successful treatment outcomes and help their overall health."
"This is an important step that will ultimately help patients manage a disease so they can save their teeth and improve their overall health. It is exciting to have the opportunity to deploy in dentistry the laboratory testing already so frequently used by physicians, and to have partners who already use advancing technologies in their practices," says Dr. Atcha. We are the Center for Oral Medicine that practices 21st century Dentistry in a caring and a compassionate environment.
OralDNA Labs, Inc. is a specialty diagnostic company created to advance clinical testing in the dental community. Our goal is to help the dental profession achieve better clinical outcomes by providing reliable, definitive and cost effective clinical tests that drive the detection and prognosis of disease at an earlier, more treatable stage, with an initial focus on periodontal disease.
Periodontal disease is a bacterial infection that causes an inflammatory response. Periodontal disease is present in an estimated three quarters of the adult population in the United States, with 30-35% of this population having a genetic trait which Predispose these individuals to more serious forms of the disease. If patients are not properly diagnosed and treated at early stages, periodontal disease can lead to bone loss, tooth loss and implant failure. Research now suggests an increased risk to a number of systemic diseases when chronic periodontal infections are left untreated. Says Dr. Atcha, "Our Doctors and Hygenists are passionate about elevating the care we provide to our patients to the next level!"
# # #